There are only two GLP-1 agonists that are TGA approved for weight loss, semaglutide (Wegovy brand) and liraglutide (Saxenda)
TB-500 complements these effects by enhancing cell migration, improving tissue flexibility, and increasing nutrient delivery through new blood vessel formation
Per the same safety document, the most commonly reported side effects are typically mild and tend to resolve after the first several weeks: nausea, vomiting, diarrhea, constipation, abdominal pain, upset stomach, reflux, headache, fatigue, and dizziness, along with possible injection-site swelling, redness, or itchiness
Both are once-weekly injections you can administer at home after instruction
[DOI] [PubMed] [Google Scholar] 226.Tohyama Y., Sikiri P., Diksic M
If I'm at the store, babe, you need anything from the store